首页> 外文期刊>Acta Haematologica >Primary Bone Lymphoma: A Clinical Analysis of 17 Patients in a Single Institution
【24h】

Primary Bone Lymphoma: A Clinical Analysis of 17 Patients in a Single Institution

机译:原发性骨淋巴瘤:单机构17例临床分析

获取原文
获取原文并翻译 | 示例
       

摘要

Primary bone lymphoma (PBL) comprises less than 1% of all malignant lymphomas. Because few studies of PBL have been conducted in Japan, the characteristics of Japanese patients with PBL have not been fully elucidated. We retrospectively analyzed 17 patients diagnosed with PBL at our institution between 2001 and 2011. Median patient age was 60 years. Eleven patients had diffuse large B-cell lymphoma and 2 patients had T-cell lymphoma histology. The spine was the most frequently involved site at the time of presentation. There were 11 patients with stage IV disease and 11 patients with high or high-intermediate risk according to the International Prognostic Index (IPI). Thirteen patients achieved complete response (CR) after initial treatment. At a median follow-up of 31 months, the 3-year overall survival (OS) and progression free survival were 63.5 and 49.9%, respectively. Localized disease, low or low-intermediate IPI, and CR after initial treatment were associated with a good outcome in patients with PBL and significantly associated with a better OS. Spine involvement and T/NK-cell phenotype are more frequent in Japanese than in Caucasian patients with PBL. (C) 2015 S. Karger AG, Basel
机译:原发性骨淋巴瘤(PBL)占所有恶性淋巴瘤的不到1%。由于在日本对PBL的研究很少,因此尚未完全阐明日本PBL患者的特征。我们回顾性分析了2001年至2011年间在我们机构中诊断为PBL的17例患者。患者中位年龄为60岁。 11例患有弥漫性大B细胞淋巴瘤,2例患有T细胞淋巴瘤组织学。在介绍时,脊柱是最常受累的部位。根据国际预后指数(IPI),有11例IV期疾病患者和11例高危或高中危患者。初次治疗后有13例患者获得完全缓解(CR)。中位随访31个月,其3年总生存率和无进展生存率分别为63.5%和49.9%。初治后局部疾病,低或低中位IPI和CR与PBL患者的预后良好相关,并且与OS更好相关。日本人的脊柱受累和T / NK细胞表型比白种人PBL患者更为常见。 (C)2015 S.Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号